Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
We first invested in Danaher, a company focused on biotechnology, life sciences and diagnostics, in the first quarter of 2016, attracted by its disciplined capital allocation, differentiated operating culture and consistent FREE cash flow generation. The business is...
— Aristotle/Saul Global Equity Fund
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on Danaher Corporation
Danaher Corporation is an essential designer and manufacturer of advanced instruments, diagnostic tools, and biological consumables used across pharmaceutical laboratories and medical research facilities worldwide. The investment manager...
Danaher Corporation faces challenges in its bioprocessing segment, with guidance indicating lower-than-expected growth. The company's reliance...